Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors
Mengwu Xiao, Lvjie Xu, Ding Lin, et al.
European Journal of Medicinal Chemistry (2021) Vol. 213, pp. 113161-113161
Closed Access | Times Cited: 16

Showing 16 citing articles:

Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Yiman Zhai, Tingyu Wang, Yunmei Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8011-8011
Open Access | Times Cited: 39
Anti-viral activity of thiazole derivatives: an updated patent review
Thoraya A. Farghaly, Amani M.R. Alsaedi, Noof A. Alenazi, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 7, pp. 791-815
Closed Access | Times Cited: 28
Structure-based drug design, molecular dynamics simulation, ADMET, and quantum chemical studies of some thiazolinones targeting influenza neuraminidase
Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 23, pp. 13829-13843
Closed Access | Times Cited: 14
Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase
Hongyu Jiang, Zongde Zhang
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
A Literature Review Focusing on the Antiviral Activity of [1,2,4] and [1,2,3]-triazoles
Thoraya A. Farghaly, Ghada S. Masaret, Sayed M. Riyadh, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 17, pp. 1602-1629
Closed Access | Times Cited: 8
Antiviral Activity of Pyrimidine Containing Compounds: Patent Review
Thoraya A. Farghaly, Marwa F. Harras, Amani M.R. Alsaedi, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 821-851
Closed Access | Times Cited: 13
Emerging antiviral therapies and drugs for the treatment of influenza
Jinshen Wang, Yihang Sun, Shuwen Liu
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 4, pp. 389-403
Closed Access | Times Cited: 11
RETRACTED: In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Heliyon (2022) Vol. 8, Iss. 8, pp. e10101-e10101
Open Access | Times Cited: 8
Design, synthesis, and in vitro and in silico studies of 1,3,4-thiadiazole-thiazolidinone hybrids as carbonic anhydrase inhibitors
Narges Hosseini Nasab, Hussain Raza, Young Seok Eom, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 29, pp. 13710-13720
Closed Access | Times Cited: 4
Modular Biomimetic Strategy Enables Discovery and SAR Exploration of Oxime Macrocycles as Influenza A Virus (H1N1) Inhibitors
D. Xu, Ying Gong, Lianju Zhang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8201-8224
Closed Access | Times Cited: 1
In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L
Chuipu Cai, Lvjie Xu, Junfeng Fang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022
Roberto Romeo, Laura Legnani, Maria Assunta Chiacchio, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2507-2549
Closed Access | Times Cited: 2
Discovery of Neuraminidase Inhibitors based on 3D‐QSAR, Molecular Docking and MD Simulations
Xiuyan Yu, Xuemin Zhao, Qingyu Zhang, et al.
ChemistrySelect (2023) Vol. 8, Iss. 12
Closed Access | Times Cited: 1
Design, Synthesis, and Biological Activity of a Novel Series of 2-Ureidonicotinamide Derivatives Against Influenza A Virus
Chao Zhang, Jun-Jie Xiang, Jing Zhao, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 26, pp. 4610-4627
Closed Access | Times Cited: 1
Design, synthesis and biological evaluation of oxalamide derivatives as potent neuraminidase inhibitors
Xing Yong Zhang, Li Ping Cheng, Zhi Jian Zhong, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 28, pp. 13533-13539
Closed Access | Times Cited: 1
Recent Efforts in Identification of Privileged Scaffolds as Antiviral Agents
Yogesh Yadav, Kavita Singh, Sunil Sharma, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 10
Closed Access
Page 1

Scroll to top